OTC Medicines

grandfather and grandchild laying on grass with a toy airplane

Research Reports

Assessing Consumer Benefits of Allergy Rx-to-OTC Switches

This study focused on assessing the overall consumer benefits of allergy Rx-to-OTC switches.

Mar 1, 2017

Rx-to-OTC Switch

Submission

Comments to FDA: Isolated or Synthetic Non-Digestible Carbohydrates

CHPA appreciates this opportunity to provide comments on FDA Guidance detailing the agency’s process for evaluating data on the beneficial physiological effects of isolated or synthetic non-digestible carbohydrates.

Feb 13, 2017

Dietary Supplements

Press Releases and Statements

National Survey Shows Teen Abuse of OTC Cough Medicine Remains at All-Time Low

“The results of this year’s Monitoring the Future survey demonstrate that prevention through education works,” Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville said.

Dec 13, 2016

Ingredient Safety

Press Releases and Statements

CHPA Applauds Alaska Lawmakers for Age-18 Sales Law on Cough Medicine

Nov 28, 2016

Ingredient Safety

Press Releases and Statements

Over-the-Counter Cough Medicines Will Save Consumers, U.S. Healthcare System Billions Over Next Decade

A recent study conducted by Charles River Associates, a leading global consulting firm, has quantified the savings consumers and the healthcare system receive from the over-the-counter (OTC) availability of the widely used cough suppressant dextromethorphan (DXM).

Nov 1, 2016

Ingredient Safety

Man wrapped in a blanket blowing his nose.

Research Reports

Managing Access to Dextromethorphan: Cost Implications of a Potential Over-the-Counter to Prescription-Only Conversion

Government officials have tried to balance the positives of OTC access against the negatives of potential abuse. This paper aims to inform this discussion by quantifying various costs that would result if products with DXM were converted from OTC to Rx.

Oct 1, 2016

two flasks and a beaker on a table in a lab

Submission

Comments to USP: Multiple Active Ingredient Product Monographs

Letter to Drs. Femia and Santos regarding multiple active ingredient product monographs.

Sep 9, 2016

Infographic

Over the Next Ten Years DXM Will Save Consumers and the Healthcare System $22-31 Billion

Sep 1, 2016

hands in sterile gloves holding manufactured white tablets

Submission

Comments to FDA: Quality Attribute Considerations for Chewable Tablets

Our member companies generally support the recommendations found in the guidance but have concerns about the scope of hardness measurements and maximum break strength value.

Aug 16, 2016